ThermoGenesis Holdings, Inc. THMO

THMO Company Overview

ThermoGenesis Holdings, Inc. (NASDAQ: THMO) is a biotechnology and medical technology company focused on automated cell processing, cell preservation, and point-of-care blood processing technologies. The company operates primarily in the regenerative medicine, cell and gene therapy, and biobanking industries. Its core business centers on developing and commercializing automated systems, consumables, and related services used in the processing and storage of cellular therapies and blood-derived products. Revenue has historically been generated through the sale of capital equipment, single-use disposables, bioprocessing tools, and service-related activities tied to cell therapy workflows.

The company evolved from its original focus on cord blood banking and cryopreservation technologies into broader regenerative medicine and cell-processing applications. Through acquisitions and internal development, ThermoGenesis expanded into automated manufacturing platforms designed to support clinical and commercial-scale cell therapy production. The company has positioned itself around automation and closed-system processing technologies intended to reduce contamination risk, improve workflow efficiency, and support regulatory compliance for advanced therapies and laboratory applications.